Introduction
============

Today\'s major Ad vectors used in clinical applications are derived from the species C serotypes Ad2 and Ad5 which efficiently infect a variety of post-mitotic cells, including specialized tissues of the upper respiratory epithelium and the gut, in addition to many tumor cells. Their biology is very well characterized (for reviews, see, [@bib63], [@bib75], [@bib83]). Species C entry into epithelial cells occurs after virus binding to the Coxsackie virus B Ad receptor (CAR) ([@bib6]) followed by engagement of αv containing heterodimeric integrins as secondary receptors ([@bib104]), which facilitate viral endocytosis and signaling into target cells ([@bib61], [@bib95]). Although species C Ads efficiently infect a number of cells and tissues, the lack of CAR or integrin expression may limit their general usefulness for gene therapy.

Recently, recombinant species B Ads or fiber swapped Ad vectors in which the fiber protein of the commonly used Ad5 is swapped with species B Ad fibers have gained interest for gene therapy and vaccination approaches. Species B Ads are divided into B1 and B2 subspecies. The B1 group comprises of Ad3, Ad7, Ad16, Ad21, and Ad50 and predominantly infects the upper respiratory tract, whereas the B2 group serotypes Ad11, Ad14, Ad34, and Ad35 are associated with kidney and urinary tract infections ([@bib79], [@bib103]). Infections with B1 Ads are a major cause of acute febrile and severe respiratory illness among military recruits ([@bib23]). In particular, the widespread Ad3 and Ad7 account for 13% and 19.7% of all Ad isolates typed and reported to WHO ([@bib103]). They are considered highly virulent and have been associated with acute clinical manifestations of considerable severity, residual lung damage, and fatal outcomes in children and military recruits in the US (for recent report, see [@bib76]). Seventeen genome types of Ad3 have been identified ([@bib56]). These variants have been noticed to segregate in different geographic areas, time periods, and clinical conditions.

A major difference between the species C and the species B Ads is the receptor usage, which might help the species B Ads to overcome host restrictions, as suggested in early studies ([@bib19], [@bib20], [@bib32], [@bib73], [@bib90]). Using different approaches, several groups have recently identified the membrane cofactor CD46 as an attachment receptor for species B serotypes, including Ad11 ([@bib80]), Ad35 ([@bib31]), and Ad3 ([@bib87]). Most of the downstream steps of productive virus infection are, however, unknown. It is for example unclear if integrins or other proteins act as secondary receptors for virus uptake ([@bib59], [@bib82]) or if virus attachment to CD46 is sufficient for uptake as CD46 is apparently internalized by multiple endocytic pathways in noninfected cells, including macropinocytosis and clathrin-mediated endocytosis ([@bib14]). Despite this shortage of knowledge, recombinant species B-based replication defective vectors have been developed for Ad35 ([@bib33], [@bib77], [@bib81], [@bib101]) and Ad11 ([@bib43], [@bib93]). Interestingly, these vectors show an extended tropism compared to species C vectors and infect hematopoietic and dendritic cells. Similarly, replication-competent or replication-defective viral vectors derived from Ad7 have been used for vaccine strategies ([@bib1], [@bib57], [@bib66]). An extended tropism was also demonstrated for fiber swapped Ad vectors containing fibers of species B viruses such as Ad3 ([@bib50], [@bib91], [@bib102]), Ad11 ([@bib89]), and Ad35 ([@bib37], [@bib38], [@bib54], [@bib71], [@bib82], [@bib109]). To generate a tool for characterization of host cell--Ad3 interactions, we constructed a recombinant E1-deleted Ad3 vector expressing eGFP using the bacterial artificial chromosome (BAC) strategy, and we report here the complete nucleotide sequence of serotype Ad3 (GB) (GenBank accession no. [DQ086466](DQ086466)). This information will serve as a reference for further characterization of this prototype species B virus strain and facilitate the development of genome-based molecular diagnostic tools of Ad infections.

Results and discussion
======================

Nucleotide sequence and genome organization
-------------------------------------------

Based on primers deduced from partial Ad3 sequences ([Table 1](#tbl1){ref-type="table"} ), the full genomic sequence of Ad3 prototype GB with an overall size of 35,343 base pairs was determined by sequencing both strands using the progressive specific primer method (GenBank accession no. [DQ086466](DQ086466)). Sequence identity between our sequence and the previously determined partial sequences varies between 95.8 and 100% ([Table 1](#tbl1){ref-type="table"}). Some of these differences may reflect genuine variations among strains or may have resulted from cloning artifacts or sequencing errors. This is also illustrated by a comparison of three recently determined prototype Ad11p sequences, where sequence discrepancies were reported in four or eleven of the 34,794 nucleotide positions ([@bib43]). Furthermore, contaminations of standard virus stocks have been noticed ([@bib69]).Table 1Previously published human adenovirus 3 sequences used for primer designSequence originGenBank Accession No.Reference% Homology compared to the discussed sequence (number of differences)Region (bp)Ad3 complete sequence[DQ086466](DQ086466)This publication1--35,342Ad3 left end fragment containing ITR, E1A([@bib13])99.24 (12/1572)1--1569Ad3 ITR, left end[J01960](J01960)([@bib98])99.4 (1/158)3--160Ad3 ITR, left end[J01963](J01963)([@bib55])95.8 (32/770)12--762Ad3 E1A 9S protein, E1A 13S protein, and E1A 12S protein genes, complete cds[AF492352](AF492352)([@bib4])100576--1455Ad3 E1A protein gene, partial cds[AY380316](AY380316)Lin et al., 2003, unpublished99.3 (3/430)704--1134Ad3 polypeptide IX gene, complete cds[J01962](J01962)([@bib24])1003413--3965Ad3 DNA polymerase gene, partial cds[AY780207](AY780207)Chmielewicz et al., 2004, unpublished1005398--5646Ad3 virus-associated RNA, pre-terminal protein and 52/55-kDa protein genes, partial cds[U52534](U52534)Ma et al., 1996, unpublished98.3 (10/582)10,305--10,890Ad3 virus-associated RNA I and RNA II genes[U10680](U10680)([@bib51])99.7 (1/450)10,399--10,849Ad3 gene for pIIIa, pVII and penton base protein[Z29487](Z29487)([@bib17])99.8 (3/1986) (penton 100% identical)13,686--15,668 (13,905--15,540)Ad3 hexon gene[X76549](X76549)([@bib68])99.6 (10/2835) (hexon 3 aa differences)18,417--21,251Ad3 hexon gene, partial cds (nonfunctional)[AY380317](AY380317)Lin et al., 2003, unpublished97.7 (18/778)18,524--19,295Ad3 hexon gene, partial cds[AY684873](AY684873)Ju et al., 2004, unpublished98.7 (5/397)19,010--19,406Ad3 L3--23-kDa gene for chymotrypsin-like endoprotease[X13271](X13271)([@bib46])99.8 (2/1273)20,917--22,190Ad3 E3 region[M15952](M15952)([@bib86])99.9 (3/4379)26,993--31,372Ad3 fiber polypeptide gene[X01998](X01998)([@bib85])10031,118--32,447Ad3 fiber protein gene, partial cds[AY380318](AY380318)Lin et al., 2003, unpublished98.7 (9/673)31,406--32,079Ad3 ITR, right end[J01961](J01961)([@bib98])99.4 (1/158)35,183--35,340[^1]

The Ad3 plus strand has a base composition of 25.29% A, 25.72% C, 25.33% G, and 23.66% T ([Table 2](#tbl2){ref-type="table"} ). The overall GC content of Ad3 is 51.05%, which is well within the reported range of 50--52% for species B serotypes ([@bib83]) and very similar to the 51.03% GC content of Ad7 ([@bib70]). In contrast, the GC content of B2 serotypes was reported to be 48.88% for both Ad11 and Ad35. The 51.22% GC content of Ad40 is closest to Ad3, whereas Ad5 of species C, Ad17 of species D, and Ad4 of species E all have higher GC content than Ad3 ([Table 2](#tbl2){ref-type="table"}). Nucleotide sequence comparison between Ad3 and other human Ads revealed the highest degree of identity to species B1 Ad7, amounting to 96.43% ([Table 3](#tbl3){ref-type="table"} ) followed by 82.56% identity to Ad11p and 82.45% to Ad35p, both of species B2. Sequence identity to the species C Ad5, species D Ad17, species E Ad4, and species F Ad40 amounted to 62.75, 65.74, 73.18, and 59.44%, respectively. Thus, Ad3 differs distinctly from the other human Ad species, with the exception of B1 Ad7. The difference among the B1 serotypes is comparable to the 98.14% identity found among the B2 Ad11/35 serotypes or the 94.7% found among the Ad2/5 serotypes ([@bib12]). The next closely related sequence to Ad3 is the species E Ad4 (73.18% identity), in agreement with the earlier notion that Ad4 exhibits close evolutionary relationship to the species B viruses ([@bib5]). On the other side, Ad4 revealed a closer phylogenetic relationship with chimpanzee Ads (simian Ads) rather than with other human Ads, which let to the speculation that human Ad4, the single member of species E, emerged through a recent zoonosis ([@bib69]).Table 2Base composition and GC contents of selected human adenovirus genomesAd speciesAd serotypeGenBank Accession No.Mol%% GC contentACGTAAd12[NC001460](NC001460)27.3423.4823.0426.1446.52B1Ad3[DQ086466](DQ086466)25.2925.7225.3323.6651.05B1Ad7[AY594255](AY594255)25.3725.7825.2523.6151.03B2Ad11p[AF532578](AF532578), [AY163756](AY163756), [AY598970](AY598970)[a](#tblfn1){ref-type="table-fn"}26.0424.4224.4625.0848.88B2Ad35p[AY271307](AY271307)26.0424.4024.4925.0848.88CAd5[AC000008](AC000008)23.2928.0327.1621.5155.20DAd17[AF108105](AF108105)22.7628.1428.4420.6656.58EAd4[AY458656](AY458656)21.9528.9328.7220.3957.65FAd40[L19443](L19443)24.8726.2125.0123.9151.22[^2]Table 3Percent genome homology among selected human adenovirus genomesTypeSpeciesAB1B1B2B2CDEFAd12 ([NC001460](NC001460))Ad3Ad7 ([AY594255](AY594255))Ad11p ([AF532578](AF532578))Ad35p ([AY271307](AY271307))Ad5 ([AC000008](AC000008))Ad17 ([AF108105](AF108105))Ad4 ([AY458656](AY458656))Ad40 ([L19443](L19443))Ad1210060.1460.3560.1759.9959.7858.9458.7761.52Ad310096.4382.5682.4562.7565.7473.1859.44Ad710083.6582.8462.9465.5572.9959.36Ad11p10098.1461.5463.6270.1759.16Ad35p10061.5963.6970.2259.15Ad510062.7164.2358.94Ad1710068.8659.69Ad410060.17Ad40100

Subsequent analysis of the translational features of Ad3 led to the identification of potential open reading frames (ORFs) with sequences in general longer than 300 bp, comparison of the deduced amino acid sequences to other members of the human *Mastadenovirus*, in particular Ad5, 7, 11, and 35 ([@bib12], [@bib33], [@bib60], [@bib70], [@bib92]). [Fig. 1](#fig1){ref-type="fig"} summarizes the Ad3 genome organization containing the 39 identified putative coding regions, the seven hypothetical coding regions, and the two virus-associated (VA) RNAs. Similar to previously reported sequences from other human Ad serotypes, Ad3 shows highly organized genome structure with five early transcription units, E1A, E1B, E2, E3, and E4, two delayed early units IX and IVa2, and one late unit, the major late unit MLTU. Several of these potential Ad3 ORFs are novel, including seven hypothetical ORFs that are conserved among other serotypes, but for which no biological function has been reported. Their putative function needs to be confirmed independently.Fig. 1Genome organization of human Ad3. The map of the Ad3 genome (35,343 bp) is divided into 100 map units (mu). The genome consists of five early transcription units, E1A, E1B, E2, E3, and E4, two delayed early units IX and IVa2, and one late unit, the major late unit. 39 potential protein-coding regions and the direction of transcription are shown as solid arrows, relative to their position and orientation. Most late gene transcripts contain the tripartite leader consisting of three spliced leader sequences (L1--L3) at their 5′ ends. Splice events contributing to the transcript generation are indicated by diagonal thin lines. In addition, the Ad3 genome encodes VA RNA I and II transcription units and seven hypothetical (hyp) ORFs with unknown biological functions.

Noncoding motifs
----------------

[Table 4](#tbl4){ref-type="table"} lists the predicted noncoding motifs of the Ad3 genome. The ITRs were confirmed to be 136 bp in length, ending with the sequence CTATCTATAT as for Ad7. This sequence differs from the consensus motif CATCATCAAT found in most other human Ads sequenced so far, including species B2 serotypes ([@bib60], [@bib81], [@bib93]). The 136 bp ITR sequence reported here is identical to the sequence reported earlier for human Ad3 ([@bib98]), except for a G--C mismatch at position 91. Two further sequence determinations ([@bib55], [@bib13]) confirmed our sequencing at this location (note that the sequence reported by Cogan is not available in electronic format). The entire Ad3 ITR sequence is very similar to the 136 bp ITR of the closely related Ad7 (Greiner strain) ([@bib84]), except for seven mismatches. Interestingly, recent sequencing of the Ad7 (Gomen strain) suggested an ITR of only 108 bp ([@bib70]) and ten mismatched nucleotides compared to Ad3. The terminal 22 nucleotides of Ad3 and Ad7 are identical to human Ad4, in agreement with the earlier notion that Ad4 exhibits very high sequence similarity in its E1A (0 to 5.5 map units) and E2 regions (62 to 66 map units) to group B Ads ([@bib53], [@bib97]). The Ad3 ITR contains the conserved ATAATATACC motif (base pairs 9 to 18), the minimum sequence necessary to interact with a complex of pTP and DNA polymerase during viral DNA replication ([@bib11]). The consensus binding motifs for the host factors NFI/CTFI (bp 26 to 39) and NFIII/Oct-1 (bp 40 to 50) were found to be located at positions similar to Ad5 ([@bib39]).Table 4Predicted noncoding motifs of the adenovirus 3 genomeMotifDescriptionPositionCTATCT..TGACGTITR1--136ATAATATACCDNApol-pTP binding site9--18 (ITR)TGGAATGGTGCCAANFI binding motif26--39 (ITR)CATGTAAATGANFIII binding motif40--50 (ITR)TATTTATATA box for E1A480--485AATAAAPolyA signal for E1A[a](#tblfn2){ref-type="table-fn"}1494--1499TATATATATA box for E1B1549--1554TAAAGTTATA box for pIX3384--3389AATAAAPolyA signal pIX[a](#tblfn2){ref-type="table-fn"}3909--3914AATAAAPolyA signal for E2B[a](#tblfn2){ref-type="table-fn"} (overlapping with end of cds)3947--3952cTGATTGGCTTInverted CAAT box for MLP5821--5830GGCCACGTGACCUpstream element for MLP5840--5851GCCGGGGGGGMAZ binding motif for MLP5862--5871TATAAAAGTATA box for MLP5872--5879GGGGGCGGGCCMAZ/SP1 binding motif for MLP5879--5889TCACTGTInitiator element for MLP5901--5907TTGTCAGTTTCDE1 for MLP5988--5998AACGAGGAGGATTTGADE2a and DE2b for MLP6003--6018AATAAAPolyA signal for L113,830--13,835AATAAAPolyA signal for L2[a](#tblfn2){ref-type="table-fn"}17,496--17,501AATAAAPolyA signal for L3[a](#tblfn2){ref-type="table-fn"}21,938--21,943AATAAAPolyA signal for E2A[a](#tblfn2){ref-type="table-fn"}21,950--21,955cTTAAE2 TATA-box-like element26,639--26,642cTATAATATA box for E327,085--27,089AATAAAPolyA signal for L427,712--27,717AATAAAPolyA signal for E3A29,001--29,006AATAAAPolyA signal for E3B[a](#tblfn2){ref-type="table-fn"}31,181--31,186AATAAAPolyA signal for L5[a](#tblfn2){ref-type="table-fn"}32,335--32,340AATAAAPolyA signal for L6[a](#tblfn2){ref-type="table-fn"}34,866--34,871AATAAAPolyA signal for E4[a](#tblfn2){ref-type="table-fn"}32,352--32,357cTATATATTTATA box for E435,034--35,040cATAATATACCDNApol-pTP binding site35,305--35,318cCTATCT..TGACGTITR35,208--35,343c[^3][^4]

Four canonical TATA box sequences conforming to the consensus TATAWADR (W designating A or T, D designating G, A, or T, and R designating G or A, respectively) were identified, including those for E1B, E3, E4, and MLP ([Table 4](#tbl4){ref-type="table"}). Furthermore, the E1A and E2A promoters contain the TATA-like box elements TATTA and TTAA, respectively, as described previously ([@bib41], [@bib55]). The Ad3 E2A promoter contains one TATA-like box less than Ad5. It was suggested that the lack of the second TATA-like box together with the absence of a minor cap site indicated that E2A and E2B transcripts both start at the same major cap site ([@bib41]). The upstream sequence of the Ad2 IVa2 promoter lacks a TATA element but contains an unusual TATAGAAA element downstream of the transcription start site at position +21 to +14 of the transcribed strand ([@bib9]). More distal IVa2 promoter elements overlapping with the control region of the MLP may provide additional transcriptional activations. Similarly, we identified a TATA-like element TAAAGT about 40 nucleotides upstream of the Ad3 protein IX promoter region apparently lacking a TATA box as Ad5 ([@bib24]). Our upstream element is identical to the one recently described for Ad7 ([@bib70]). Furthermore, we identified thirteen polyadenylation signal sequences, but we found no site for the E1B region. As for Ad5, we found two polyadenylation signals in the E3 region, potentially giving rise to E3A and E3B transcripts. This feature is absent in Ad4, Ad7, and Ad11, where only one polyadenylation signal in E3 is known. A polyadenylation signal was also found for the L6 region encoding the putative agnoprotein ([@bib60]).

Comparing ORFs of early regions
-------------------------------

[Table 5](#tbl5){ref-type="table"} lists the predicted sizes and positions of translation initiation and termination for the 46 identified putative Ad3 ORFs. The early E1A gene gives rise to the first viral transcript after DNA arrival in the nucleus ([@bib83]). The E1A proteins are the major transactivators controlling viral replication. The putative splice variants of Ad3 13S, 12S, and 9S of E1A were mapped according to previously published sequences for the Ad3 E1 region ([@bib4], [@bib13]), the latter perfectly matching the herein described sequence ([Table 1](#tbl1){ref-type="table"}). Similar E1A ORFs have been described for other B species serotypes including Ad7 ([@bib21], [@bib70]), Ad11 ([@bib60], [@bib93]), and Ad35 ([@bib33]). In the case of Ad5, the 13S, 12S, and 9S E1A proteins of 32, 26, and 6 kDa are thought to arise by differential splice site selection modulated by virus-induced stress signaling ([@bib94], [@bib100]).Table 5Forty-six predicted translation products and VA RNA genes of the Ad3 genomeFeatureMW (kDa)[a](#tblfn3){ref-type="table-fn"}Ad5 (others) equivalentATGSTOPE1 region E1A 13s protein28.4E1A 13s mRNA 32-kDa576 j12501155 1455 E1A 12s protein24.6E1A 12s mRNA 26-kDa576 j12501062 1455 E1A 9s protein6.7E1A 9s mRNA 6-kDa576 j1250647 1351 E1B 21-kDa20.5E1B 19-kDa16032139 E1B 55-kDa54.7E1B 55-kDa19083386Intermediate transcription regions IX and IVa2 Protein IX14.1IX34803896 Protein IVa250.6IVa25572c j5281c5560c 3948cE2 region E2B DNA pol128.6DNA pol8419c5051c E2B pTP73.8Terminal protein10,344c8422c E2A DBP58.3DBP23,557c22,004cE3 region E3 12.1-kDa12.1E3 12.5-kDa27,40327,723 E3 16-kDa16.027,67728,117 E3 gp19-kDa19.0gp19-kDa28,10228,620 E3 20.1-kDa20.028,65029,189 E3 20.5-kDa20.529,20229,771 E3 9-kDa9.029,78630,019 E3 10.2-kDa10.330,06130,336 E3 15.2-kDa15.230,34130,745 E3 15.3-kDa15.230,73831,148E4 region E4 ORF114.1E4 ORF134,953c34,576c E4 ORF216.0E4 ORF B34,579c34,145c E4 ORF313.6E4 ORF334,148c33,795cE4 ORF414.3E4 ORF433,786c33,418c E4 ORF6 34-kDa34.7E4 34-kDa33,515c32,616c E4 ORF6/716.0E4 ORF6/733,515c j32,619c33,342c 32,368cVA RNA region VA RNA I--VA I10,42210,591 VA RNA II--VA II10,66610,837L region L1 52/55-kDa43.852/55-kDa protein10,86912,026 L1 pIIIa65.7Pro-IIIa12,05113,817 L2 III (penton base)61.8Penton protein13,90515,539 L2 pVII21.2Pro-VII15,55116,129 L2 pV40.1Pro-V16,17217,221 L2 pX8.3Pro-X17,25017,477 L3 pVI27.1Pro-VI17,55318,305 L3 II (hexon)106.2Hexon18,41821,252 L3 23-kDa (protease)23.823-kDa (protease)21,28921,918 L4 100-kDa92.3L4 100-kDa protein23,58826,074 L4 22-kDa22.522-kDa25,77626,375 L4 33-kDa30.933-kDa25,776 j26,29426,244 26,649 L4 pVIII24.9Pro-VIII26,72027,403 L5 IV (fiber)34.8L5 IV fiber31,36832,327 L6 (agnoprotein, hyp)18.8--33,64134,150Miscellaneous proteins 20.3-kDa (hyp)20.3(Ad7/Ad4) 20.6-kDa/19.4-kDa (hyp)51235692 11.5-kDa (hyp)11.5(Ad7/Ad11/Ad35/Ad4) 11.5-kDa (hyp)61446464 21.9-kDa (hyp)21.9(Ad7/Ad4/Ad11) (hyp)78298425 14.6-kDa (hyp)14.6(Ad7/Ad4) 14.5-kDa (hyp)85488949 19-kDa (hyp)19k(Ad7) E2B 19-kDa (hyp)7389c6868c 11.5-kDa (hyp)11.5(Ad7) E2B 11.3-kDa (hyp)9857c9543c[^5][^6]

The E1B region of Ad3 gives rise to two predicted proteins of 21 and 55 kDa corresponding to the small and large T antigen, respectively, representing the first report of an Ad3 E1B sequence. Similar E1B ORFs have been described for other B species serotypes including Ad7 ([@bib22]), Ad11 ([@bib60], [@bib93]), and Ad35 ([@bib33]). The 21- and 55-kDa proteins of Ad3 show identities of 50 and 53% to Ad5 E1B proteins but show 99 and 98% identity to Ad7 and 88 and 85% identity to Ad11, respectively ([Table 6](#tbl6){ref-type="table"} ). In the species C serotypes, both proteins are mainly involved in counteracting apoptosis.Table 6Comparison of primary amino-acid sequences of predicted Ad3 proteins with corresponding proteins of other human adenovirusesSpeciesABCDEFB1B2SerotypesAd12Ad7Ad16Ad21Ad11Ad14Ad35Ad2Ad5Ad8Ad9Ad17Ad36Ad4Ad40Ad41E1 region E1A 12s protein39987676364153563335 E1A 13s protein42989896788877363658434458574042 E1A 9s protein98727249 E1B 21-kDa41988887504852536144 E1B 55-kDa47988585535357627147Intermediate transcription regions Protein IX581008889515161785757 Protein IVa278999393828285859180E2 region E2B DNA pol73989191767681808872 E2B pTP77999494808080798973 E2A DBP5096838354546059745151E3 region E3 12.1-kDa679910099878888555566666679 E3 16-kDa979894626162302735283354 E3 gp19-kDa23989898807080323635353463 E3 20.1-kDa2497979775737532323231 E3 20.5-kDa96979862616233273333 E3 9-kDa66819840424248 E3 10.2-kDa521009810093959351476564754243 E3 15.2-kDa299895966464633731434449483232 E3 15.3-kDa568787888686864953747776795151E4 region E4 ORF15097969546464568 E4 ORF230979392323251395828 E4 ORF3611009898494972728657 E4 ORF4379592924545435333 E4 ORF6 34-kDa52979897595969677171 E4 ORF6/74297979747476634L region L1 52/55-kDa731009495706979798477 L1 IIIa73999393757579798872 L2 III (penton base)7399858570707676847273 L2 pVII749891916969818769 L2 pV59998484616065647957 L2 pX62100/9992926969778867 L3 pVI64998686636370707961 L3 II (hexon)78958685868577778483847978 L3 23-kDa (protease)8198898980808379898183 L4 100-kDa64978585646962766563 L4 22-kDa43987877505153637345 L4 33-kDa9869694647624038 L4 pVIII769899999493947979828382907981 L5 IV (fiber)335762585857582929282831313127 L6 (agnoprotein)979495

The DNA-binding protein (DBP) of E2A together with the two genes of the early E2B region encoding the DNA polymerase and the pre-terminal protein (pTP) provide the machinery for viral replication. A detailed characterization of the Ad3 E2A promoter ([@bib41]) and partial sequences of the pTP and DNA polymerase are available from the databank, but the sequence of the Ad3 DBP has not been reported previously. The Ad3 58.3-kDa DBP, the 73.8-kDa pTP, and the 128.6-kDa DNA polymerase revealed 54%, 80%, and 76% identity to the corresponding Ad5 proteins. The two zinc-binding domains in DBP were found to be fully conserved among Ad3, Ad7, Ad11, and Ad5. The first zinc-binding domain characterized by the consensus sequence HXCX8CXH is located at amino acid positions 259 to 273. Four distributed cystein residues at amino acid positions 383, 385, 437, and 454 characterize the second domain. The putative bipartite nuclear localization signal ~44~PPKRN~48~ and ~84~PPKKKP~89~ in the N-terminal domain of Ad11 DBP ([@bib60]) is conserved in Ad3 and in Ad7 ([@bib70]).

The E3 region together with the fiber gene is the most divergent part of the Ad genome ([@bib5]). The E3 polymorphism has been suggested to be in part responsible for clinical manifestations, different for Ads of different subspecies ([@bib108]). Depending on the virus species, the E3 region encodes five to nine proteins that are all involved in antagonizing the host immune response to the viral infection ([@bib45]). Although all seven Ad2/5 E3 proteins and the unique Ad3 20.1- and 20.5-kDa E3 proteins are expressed during infection in cultured cells ([@bib8]), the E3 genomic region is entirely dispensable for virus growth in cell culture. Our sequence analysis of E3 agrees with previous data by Signas et al. ([Table 1](#tbl1){ref-type="table"}, [Table 5](#tbl5){ref-type="table"}, [Fig. 1](#fig1){ref-type="fig"}), which also identified nine putative Ad3 ORFs ([@bib86]). These include the RID α/β 10.3- and 15.2-kDa proteins and the 15.3-kDa protein, all three of which are functionally conserved among all Ad species and are homologues of the Ad5 10.4-, 14.5-, and 14.7-kDa proteins. The Ad3 homologues of the Ad5 12.5- and gp19-kDa proteins are 12.1- and gp19-kDa, respectively. They are conserved in B, C, D, and E but not in F species. Two potential Ad3 ORFs encode the 20.1- and 20.5-kDa proteins which are of interest because their genes are absent in species C ([@bib86]). They are absent or strongly diverged in species A Ad12 and species F Ad40. The Ad3 9-kDa transmembrane protein shares high homology only to the carboxy-terminal 20 amino acid end of the Ad2/5 11.6-kDa adenovirus death protein (ADP). The function of this protein is unknown, but it has high polymorphism among Ad3/7 field isolates ([@bib49]), and notably, species B2 and F viruses lack the potential 9-kDa/ADP ORF completely. The Ad7 homologue appears to have diverged from the Ad3 E3 9-kDa sequence in an unusual way ([@bib44]) as it lacks the otherwise conserved carboxy-terminal 20 amino acids but has an insertion of 17 amino acids near the beginning of the potential ORF, completely unrelated to Ad3 or Ad2/5. This leaves only a central sequence with notable homology between Ad3 and Ad7 with a protein sequence identity of only 66%. Likewise, the potential Ad3 ORF encoding the 16-kDa protein differs substantially from Ad5 6.7 kDa equivalent. The proteins share some conserved amino acids in the carboxy terminus and the hydrophobic domain, but the Ad5 6.7-kDa protein lacks an 83-residue extension at the amino-terminal end present in Ad3 ([@bib106]).

The E4 unit is well conserved among the human Ads and encodes at least six proteins involved in transcriptional regulation, mRNA transport, DNA replication, and enhancement or inhibition of apoptosis ([@bib96]). A blast search revealed no published sequences of the Ad3 E4 region. Six potential Ad3 ORFs were identified based on sequence homology to Ad5. These include a 14.1-kDa protein related to the Ad5 ORF 1, a 16-kDa ORF2 protein, a 13.6-kDa ORF3 protein, a 14.3-kDa ORF4 protein, a 34.7-kDa ORF6 protein, and 16-kDa ORF6/7 protein. Their sequence identities to the Ad5 sequences amount to 46, 32, 49, 45, 59, and 47%, respectively, well within the range of similarity reported for E4 sequences of human species A--D ([@bib96]). The best-characterized E4 protein is ORF6, a multifunctional protein participating in all of the abovementioned processes. It contains several conserved motifs such as a cystein-rich domain in the center with an HCHC motif critical for the zinc-binding in vitro ([@bib7]). We found a conservation of the HCHC motif in Ad3 and also a conservation of an arginine-rich amphipathic α-helix domain overlapping with a nuclear retention signal of amino acids at position 236. Interestingly, the Ad9 E4-ORF1 was recently reported to be an oncogenic determinant and found to stimulate PI3-kinase via interaction with a PDZ protein leading to mammary gland tumor in female rats ([@bib30], [@bib48]). The critical PDZ-binding domain is conserved in the Ad3 sequence, but it is unknown if this domain contributes to oncogenesis.

Seven hypothetical proteins were identified in the Ad3 genome as homologues of previously determined Ad2/5, Ad4, Ad7, or Ad11 sequences. Six of these sequences are on a 5-kbp stretch corresponding to the E2B region ([Fig. 1](#fig1){ref-type="fig"}). Four potential ORFs are embedded on the sense strand and two on the complementary strand. Due to a lack of biological data, no annotation of these sequences to any of the transcription units has been made yet.

Comparing ORFs of intermediate genes and VA RNA regions
-------------------------------------------------------

The viral genes encoding the proteins IVa2 and IX are transcribed from their own promoters at an intermediate time point of infection. Protein IVa2 has two important functions. It is involved in packaging newly replicated viral DNA and has transactivating properties on the MLP promoter, where it either binds as a homodimer or a heterodimer ([@bib110]). Functional interaction between IVa2 and the rest of the packaging machinery appears to be serotype-specific. For example, the species B1 Ad7 IVa2 protein cannot package an Ad5 packaging sequence-containing chimeric virus ([@bib112]). The sequence identity of 82% between Ad3 and Ad5 IVa2 is surprisingly high, suggesting additional functions of the protein perhaps involved in housekeeping functions of adenoviral infections. As IVa2, protein IX has multiple functions (reviewed in ([@bib67]), including stabilization of the capsid, transcriptional activation, and nuclear reorganization during viral DNA replication and packaging of full-length viral DNA genomes. A carboxy-terminal leucine repeat or coiled-coil domain, conserved in the Ad3 sequence, is important for the transcriptional activity of protein IX ([@bib74]). Furthermore, Ads encode one or two small virus-associated (VA) RNAs transcribed by the RNA polymerase III, depending on the serotype. VA RNAs counteract the activity of RNA-dependent protein kinase, up-regulated by the virus-induced interferon response ([@bib52]). All serotypes of species B1, including Ad3, Ad7, Ad16, and Ad21, contain two segments encoding VA RNA I and II, in contrast to species B2 or species A serotypes which only contain one VA RNA ([@bib51]). In Ad3, the VA RNA I and II were found to be located in tandem at nucleotide position 10,422 to 10,837 of the genome, comprising 416 nucleotides.

ORFs of late region
-------------------

The Ad3 genome has six potential polyadenylation signals similar to Ad11, suggesting that the late genes of Ad3 are organized into six regions (L1--L6) expressed from the common major late promoter MLP ([@bib60]). As in other human Ads, the MLP is located at 16.6 map units from the conventional left hand end of the genome ([Fig. 1](#fig1){ref-type="fig"}, for review on MLP, see [@bib110]). Several elements have been described to control the MLP function of Ad2/5 and were found here also for Ad3 ([Table 4](#tbl4){ref-type="table"}). These include the TATA box and the initiator element INR and, in addition, upstream elements such as the inverted CAAT box, upstream promoter element UPR, and two downstream adjacent elements (DE1 and DE2b/a). The DE elements are binding sites for the IVa2 protein complex. Furthermore, two conserved GC-rich sequences flanking the TATA box presumably functioning as MAZ-, SP1- or TFIIB-binding sites were found in Ad3. A surprisingly high 80% identity of the MLP and the first leader segment of late RNAs had been noticed before between Ad3/7 and Ad2 ([@bib25]), presumably reflecting the fact that the DNA polymerase encoding sequence is located on the opposite strand.

Most viral late mRNAs contain a spliced tripartite leader (TPL) sequence of about 200 nucleotides, largely lacking secondary structure. This feature allows the translation of the downstream mRNA without the help of helicase functions, which are impaired late in infection due to dephosphorylation of eIF-4F ([@bib47]). eIF-4F helicase is necessary for scanning of the 40S ribosomal subunit on most cellular mRNAs. The TPL sequences thus give the viral transcripts a selective translation advantage. The TPLs of Ad3 are situated at nucleotide position 5903 to 5943 (41 nucleotides), nucleotide position 6962 to 7033 (72 nucleotides), and nucleotide position 9477 to 9563 (87 nucleotides) ([Fig. 1](#fig1){ref-type="fig"}). The overall length amounts to 200 nucleotides, identical to other human Ads such as Ad5 and Ad11. The different MLP transcription units encode ten of the eleven structural proteins and four helper proteins. The Ad3 L1 encodes two potential ORFs with homology to the 52/55-kDa protein and the precursor of protein IIIa (pIIIa). This precursor is cleaved by the viral 23-kDa protease, and the resulting pIIIa functions as a cementing protein linking adjacent hexon proteins at the icosahedral surface ([@bib26]). The conserved cleavage site ~568~LGGR↓G~572~ matches the substrate consensus motif (M,L,I)XGX↓G or (M,L,I)XGG↓X of the Ad2/5 protease ([@bib99]). The identity between Ad3 and Ad5 pIIIa is 75% and 99% between Ad3 and Ad7. Similar relationships of Ad3 to Ad5 and Ad7 are found for the 52/55-kDa protein, 69% and 100%, respectively.

Four Ad3 ORFs were identified corresponding to homologues of the Ad5 L2 region. These include protein III (penton base), the precursor proteins pVII, pV, and pX (also called μ). Penton base is one of three major capsid proteins, and it is involved in virus uptake following binding of its RGD motif to several αv integrins ([@bib104]). The RGD motif was found to be conserved in Ad3 penton base like in most human Ad serotypes, as judged from partial sequence information ([@bib59]). Our full-length Ad3 penton base sequence revealed a 100% match to an earlier published sequence ([@bib17]). The Ad3 penton base protein consists of 544 residues with 70% identity to Ad5 and 99% identity to Ad7. The other proteins VII, V, and X are rich in arginine and lysine, reflecting their function as DNA-binding core proteins. Protein VII is the major core protein and serves as a histone-like protein condensing the viral DNA. The arginine/lysine content of Ad5 and Ad3 pVII is very similar, 24% and 23%, respectively, reflecting their similar functions. The identities to the Ad5 homologues of pVII, pV, and pX are 69, 60, and 69%, respectively, whereas 98, 99, and 100 or 98.7% identities (for two different pX sequences) to the Ad7 homologues were found. Potential protease cleavage sites recognized by the viral 23-kDa protease are conserved in pVII and pX. The Ad3 pVII contains one potential cleavage site (~21~MYGG↓A~25~) and the pX two (~24~MLGR↓G~28~ and ~42~LGGG↓F~46~). No protease consensus motif was found in Ad3 protein V, in agreement with Ad5.

The L3 region of Ad3 encodes three proteins with homology to Ad5 proteins, the hexon (protein II), the 23-kDa cysteine protease, the sequence of which was published before ([@bib46]), and the precursor of protein VI. The major capsid protein hexon is the most abundant structural protein ([@bib78]). It carries the serotype- and species-specific determinants that are distributed over seven hypervariable regions. The Ad3 hexon sequence has been reported earlier ([Table 1](#tbl1){ref-type="table"} and [@bib68]), and it is 95% identical to Ad7 and 77% to Ad5. P23 is highly conserved among the different Ads. It catalyzes the maturational processing of six proteins, the precursors of the terminal protein (TP), protein IIIa, protein VI, protein VII, protein VIII, and protein X ([@bib58]). Virions with a defective protease assemble but fail to disassemble upon internalization and are not infectious ([@bib35]). P23 is activated by an 11-residue carboxy-terminal peptide cleaved off from the precursor of VI ([@bib58]). This is thought to happen during virion assembly in the vicinity of the replicated viral DNA and might help recruiting protein VI to the inner surface of the capsid, thus connecting hexon and the viral DNA core. Similar to Ad2/5, two conserved viral protease recognition sites near the N- and the C-terminus ~30~LNGG↓A~34~ and ~235~IVGL↓G~240~ are present in the Ad3 pVI precursor. In the case of Ad2/5, the cleaved C-terminal peptide harbors nuclear import and export signals, allowing the protein to shuttle between the cytoplasm and link hexon to the nuclear import machinery ([@bib107]). This C-terminal peptide also serves to activate the p23 protease switching protein VI function from regulation to assembly. The function of the N-terminal peptide is not known, although it has been suggested that endosomal membrane disruption occurs by virtue of an N-terminal amphipatic helix exposed upon proteolytic maturation ([@bib105]). A putative amphipatic helix sequence with hydrophobic residues is also conserved in Ad3. Precisely how membrane lysis of Ad occurs and how this is controlled by critical host factors ([@bib61], [@bib62]) is not known.

In the L4 region, four potential Ad3 ORFs with homology to Ad5 genes were identified, the 100-kDa, 23-kDa, and 33-kDa protein and the pVIII precursor protein. The 100-kDa protein is not found in mature virions but acts as a scaffold to facilitate assembly of hexon trimers and is involved in the regulation of late viral protein synthesis ([@bib83]). For Ad2, the latter has been suggested to depend on RNA-binding motifs and a coiled-coiled motif at the amino acid position 280 to 345 allowing interactions with the eukaryotic initiation factor eIF4G ([@bib15]). A critical ~329~RRK~331~-motif was found to be conserved in the Ad3 sequence. Ad3 100-kDa protein is 97% identical to the Ad7 and 64% to the Ad5 protein. The 33-kDa phosphoprotein is involved in viral assembly and shutoff of host cell translation ([@bib28]). The potential ORF for 33-kDa protein arises by splicing of an intron sequence. In Ad3, an alternative potential ORF encoding a 22-kDa protein with identical 156 amino-terminal residues and a different carboxy-terminus of 43 residues is encoded by the first exon. The only biological evidence for the existence of the smaller protein comes from the finding that a virus mutant containing an early stop codon in the first exon lost expression of two (faint) protein bands of the expected sizes ([@bib28]). The identity to the Ad7 homologue is 98% and 46% to the Ad5 homologue. The pVIII precursor protein reveals a 98% identity to the Ad7 protein and 79% identity to the Ad5 protein. Within the 227 amino acid sequence, three viral protease cleavage sites are conserved, starting at amino acid position 108, 128, and 154, respectively. pVIII is thought to stabilize the capsid, but it is not clear if it has additional functions and if all of the precursor polypeptides are incorporated into virions ([@bib26]).

L5 and L6 each contain only one potential ORF, encoding the fiber protein and the hypothetical unidentified agnoprotein. The carboxy-terminal knob of the trimeric fiber protein determines receptor binding, whereas the amino terminal domain attaches noncovalently to the penton base protein. The length of the shaft domains of species C and B viruses differs considerably due to variation of the number of shaft repeats. Like all other B species serotypes, Ad3 has short fiber shafts. The Ad3 shaft lacks the KKTK sequence, a motif suggested to bind heparan sulfate proteoglycans ([@bib88]). The Ad3 fiber sequence has a 29% identity to Ad5 fiber and a 57% identity to Ad7 fiber, consistent with earlier sequencing data ([@bib85]). This confirms the notion that the fiber proteins are the least conserved of all proteins among the human Ad serotypes in terms of nucleic acid sequence but not in terms of structure ([@bib16]). As the putative ORF encoding the 169 amino acid residues agnoprotein is highly conserved in the species B genomes and is followed by a polyadenylation signal not present in the Ad5 genome, it is likely to be expressed during infection ([@bib60], [@bib70]). It was speculated that this hypothetical protein is a putative DNA-binding protein ([@bib70]).

Construction of an E1-deleted recombinant Ad3 vector expressing eGFP
--------------------------------------------------------------------

To establish a recombinant E1-deleted Ad3 vector expressing the eGFP reporter protein, we initially employed traditional cloning in *E. coli* as described earlier ([@bib10], [@bib87]). This attempt was based on recABCD using moderate copy number entry vectors, and it was not successful (data not shown). We thus employed the single copy BAC vector pKSB2 as an acceptor, together with the recently described ET recombination system ([@bib111]). The pKSB2 plasmid supports stable maintenance of large DNA fragments in *E. coli*. For the Ad3CMV-eGFP construction, left and right terminal Ad3 sequences, separated by a zeocin selection cassette, were first cloned into pBluescript ([Fig. 2](#fig2){ref-type="fig"}A, for details see [Materials and methods](#sec1){ref-type="sec"}) followed by subcloning of the Ad3LRzeo-cassette into pKSB2 ([Fig. 2](#fig2){ref-type="fig"}B). The resulting pKSB2Ad3LRzeo was linearized and co-transformed together with wt Ad3 genomic DNA into *E. coli* DH10B pre-transformed with pKD46, which encodes the arabinose-inducible phage lambda recombinases ([Fig. 2](#fig2){ref-type="fig"}C). Homologous recombination in these cells resulted in the plasmid pKSB2Ad3wt containing the complete Ad3 genome. In contrast to our initial attempts, the efficiency of this novel recombination strategy was unexpectedly high as 9 out of 10 recovered clones carried full-length Ad3 genomes. Species C and B derived recombinant Ad genomes have been reported to be maintained as high or moderately high copy plasmids in *E. coli* ([@bib10], [@bib42], [@bib81]). Probably, this is not applicable for all Ad genomes, including Ad3. It is known that some viral genomes are unstable in *E. coli* as traditional plasmids. For example, genomes from large DNA viruses, such as herpesviruses, exceed the cloning capacity of normal cloning vectors and are thus often manipulated in BACs ([@bib64]). Besides the genome size, genome instability is another critical factor as reported for coronaviruses which are only stable in *E. coli* as BACs ([@bib3]). Whether the genome of Ad3 is particularly unstable or whether the efficiency of the ET recombination in our hands was much higher than the efficiency of the recABCD system is not known yet.Fig. 2Generation of a BAC of E1-deleted Ad3 encoding the eGFP reporter gene. (A) The plasmid pBSAd3LRzeo contains a zeocin selection cassette flanked by a 468-bp fragment of the Ad3 left end sequence and a 528-bp fragment of the Ad3 right end sequence. (B) Transfer of the *Not*IB--*Hin*dIII fragment containing the Ad3LRzeo cassette to the single copy pKSB2 plasmid. (C) Transformation of DH10B bacteria expressing the phage lambda recombinases allows homologous recombination between the *Sal*I-linearized pKSB2Ad3LRzeo and Ad3 genomic DNA, resulting in pKSBAd3wt. (D) Subsequent homologous recombination between pKSBAd3wt and a CMV-eGFP/zeo cassette flanked by short homologous sequences of 40 bp results in pKSB2 Ad3CMV-eGFP, which contains the eGFP expression cassette in reverse orientation. (E) Release of the viral genome by the flanking unique *Mlu*I endonuclease sites followed by transfection of helper 911-Ad3E1B cells yielding Ad3CMV-eGFP. (For details of the procedure, see [Materials and methods](#sec1){ref-type="sec"}.)

In order to introduce the CMV-driven eGFP expression cassette via a second homologous recombination, the PCR-generated eGFP/zeo cassette flanked by short homologous sequences was transformed into recombinase-expressing DH10B cells harboring the pKSB2Ad3wt plasmid ([Fig. 2](#fig2){ref-type="fig"}D). Insertion of the inverse-oriented expression cassette into the Ad3 sequence resulted in a 2469-bp deletion of the E1 region encompassing the sequence from nucleotide 561 to 3029. This deletion comprised the ORFs for E1A and most of E1B but left intact a residual 409-bp stretch of the pIX promoter. Similar E1 deletions had been engineered in an E1-deleted Ad35 vector ([@bib33]). The resulting BACmid pKSB2Ad3CMV-eGFP was digested with *Mlu*I to release the genomic DNA ([Fig. 2](#fig2){ref-type="fig"}E), which was subsequently transfected into helper 911-Ad3E1B cells. GFP-positive plaques were detected under the fluorescence microscope about 10 days post-transfection. Plaque-purified clones were amplified and grown to high titers. The predicted genome structure of Ad3CMV-eGFP was confirmed by restriction analysis of isolated viral DNA (data not shown).

In order to grow E1-deleted Ad3-based vectors, a modified complementation cell line was produced that expressed the Ad3 E1B 55-kDa protein. Expression of additional species B E1B 55-kDa protein was previously demonstrated to be sufficient to complement the E1 deletion of species B Ads, when expressed in helper cell lines such as PER.C6 ([@bib43], [@bib101]) or HER293 ([@bib33]). We stably transfected 911 helper cells using the pPGK-Ad3E1B-neo plasmid expressing the Ad3 E1B 55-kDa gene under the housekeeping phosphoglycerate kinase (PGK) promoter. Several clones were isolated and characterized for their expression of Ad3 E1B 55-kDa protein and ability to support the growth of Ad3CMV-eGFP virus. The results indicated that the Ad3 E1B 55-kDa protein was expressed at low levels sufficient to grow plaqueing Ad3CMV-eGFP (data not shown). For batch purification of Ad3CMV-eGFP, the 911-Ad3E1B cells were additionally transiently transfected with the pPGK-Ad3E1B-neo plasmid increasing the expression of the limiting Ad3 E1B55K protein.

Transduction of CD46-positive target cells
------------------------------------------

We next measured Ad3CMV-eGFP-mediated gene delivery to CD46-positive cells, including the stably transfected baby hamster kidney cells BHK-CD46 ([@bib87]), the human hematopoietic cell lines K562 and THP-1, and the human lung carcinoma cell line A549, which expressed both CD46 and the Coxsackie virus B Ad receptor CAR binding to Ad2/5 vectors ([@bib65]). We compared the transduction efficiency of Ad3CMV-eGFP, a chimeric Ad3 fiber-Ad5-based vector in which the fiber protein of Ad5 was swapped with Ad3 (AdCMV-eGFP-5/F3) ([@bib87]), and Ad5CMV-eGFP ([@bib65]). In CAR negative, CD46-positive BHK-CD46 cells, both Ad3CMV-eGFP and AdCMV-eGFP-5/F3 yielded dose-dependent eGFP expression, about 75- and 39-fold higher than eGFP expression from the Ad5 vector and 97- and 25-fold higher than CD46 negative parental cells (MOI 30, [Fig. 3](#fig3){ref-type="fig"} ). These results confirmed our earlier notion that CD46 efficiently mediates uptake of both Ad3 and Ad5/F3-chimeric viruses ([@bib87]). A similar boost of transgene expression was found in CD46-positive K562 cells and, to a lesser extent, in CD46-expressing THP-1 cells. For CAR- and CD46-positive A549 cells, all three recombinant vectors induced a robust transgene expression, reaching highest levels with Ad3CMV-eGFP followed by about 1.7-fold lower levels with AdCMV-eGFP-5/F3 and by 2.5-fold less eGFP with Ad5CMV-eGFP at MOI 3.3. Notably, the transduction levels of CD46-positive cells with Ad3CMV-eGFP were consistently higher with the chimeric AdCMV-eGFP-5/F3. This effect was particularly pronounced with K562 cells, although the fractions of eGFP-positive cells were comparable between the two viruses (data not shown). Similar results were reported in a study of an Ad35 and Ad5/F35-chimeric vector, where the Ad35 vector yielded more than 3-fold higher transduction of human hematopoietic stem cells than the chimeric vector, measuring the mean fluorescence intensity of GFP or luciferase transgenes ([@bib77]). Although the luciferase cassette was inserted in the reverse orientation, the authors speculated that this difference could result from the different make up of the native Ad35 and the Ad5 capsid bearing the Ad35 fibers, affecting virus entry. Another study with an Ad11-eGFP and an Ad11 fiber swapped Ad5, in contrast, reported that the percentage of transgene expressing cells from both vectors were similar except in K562 cells where the chimeric vector was apparently superior ([@bib93]). These results may not be comparable since the eGFP cassette of the Ad5/F11-chimeric vector was in the E3 region and in the E1 region of the Ad11-based vector. In our case, it is possible that slight differences in expression levels are due to the reverse orientation of the reporter cassette in Ad3CMV-eGFP, as opposed to the Ad5-based vectors carrying a forward orientated eGFP expression cassette.Fig. 3Ad3-mediated e-GFP expression in permissive human cells and CD46-transfected rodent cells. The indicated cells were incubated with eGFP expressing Ad3, Ad5, or Ad5/F3 at different MOIs. eGFP expression was analyzed 2 days post-infection by flow cytometry. Results are expressed as means of fluorescence intensity (MFI).

Conclusions
===========

We have determined the complete Ad3 sequence of 35,343 base pairs. Ad3 together with other B1 serotypes and species E Ad4 belong to the causative agents of epidemic outbreaks of acute respiratory disease. The complementation of the Ad3 sequence reported here may help to develop improved high-throughput assays for genome typing, allowing to monitor infectious diseases caused by this agent more accurately. The transduction results obtained using the E1-deleted Ad3-based eGFP vector revealed efficient entry of Ad3 into CD46-positive cells. Future use of this vector may allow answering specific questions concerning the entry pathway of Ad3 both in vivo and in cultured cells.

Materials and methods {#sec1}
=====================

Cells and viruses
-----------------

Most cells used here were described previously ([@bib87]) and were grown in Dulbecco\'s modified Eagle\'s medium (DMEM) plus 8% FCS. The molecular identity of the Ad3 stock (prototype strain GB, kindly provided by the late T. Adrian, Medizinische Hochschule Hannover, Germany) was verified by DNA restriction analysis ([@bib2]). Ad3 was grown in A549 cells, and DNA was isolated following the protocol of [@bib36].

Nucleotide sequence, gene organization, and sequence comparison
---------------------------------------------------------------

Using isolated viral DNA, the nucleotide sequence of both strands of the Ad3 genome was determined (GenBank accession no. [DQ086466](DQ086466)) starting from the published sequences for hexon (accession [X76549](X76549) ([@bib68])), E3 region (accession [M15952](M15952) ([@bib86])), penton base (accession [Z29487](Z29487) ([@bib17])), fiber (accession [X01998](X01998) ([@bib85])), E1A (accession [AF492352](AF492352) ([@bib4])), ITR and left end (accession [J01963](J01963) ([@bib55])), pIX (accession [J01962](J01962) ([@bib24])), and pTP (accession [U52534](U52534); unpublished). To confirm the exact ends of the ITR sequence, an *Nhe*I 794 bp left end fragment was subcloned into *Xba*I--*Eco*RV restricted pBluescript (ks+) (Stratagene). Sequencing reactions were performed using primers of 18 to 22 nucleotides and the chain termination kit ABI Big Dye Terminator v.3.1 (Applied Biosystems, Foster City, CA, USA) and subsequently analyzed on a 310 Genetic Analyzer (Perkin-Elmer). The raw data were assembled and verified using the sequence analysis software Sequencer (version 4.1, Gene Codes Corporation, Ann Arbor, MI, USA). Identification of putative open reading frames and the corresponding amino acid sequences, as well as general sequence comparisons, were performed using the GENtle GNU software (Mr. Magnus Manske, Germany, [http://gentle.magnusmanske.de](http://www.gentle.magnusmanske.de)). Identification and sequence comparisons of the determined putative proteins were performed with blastp from NCBI (<http://www.ncbi.nlm.nih.gov/BLAST/>). Potential splice sites of E1A were identified according to earlier published information (accession [AF492352](AF492352) ([@bib4])). Splice sites of L4 22/23k IVa2 and E4 ORF6/7 genes were identified using Wise2 (<http://www.ebi.ac.uk/Wise2/>) or NNSPLICE version 0.9 (<http://www.fruitfly.org/seq_tools/splice.html>) ([@bib72]). PolyA signals were either predicted using ERPIN ([http://tagc.univ-mrs.fr/erpin/](http://www.tagc.univ-mrs.fr/erpin/)) ([@bib34]) (marked with asterisks in [Table 4](#tbl4){ref-type="table"}) or alternatively identified based on polyA signals described for human Ad7 by [@bib69]. The TATA box consensus sequence was taken from: <http://www.epd.isb-sib.ch/promoter_elements>.

Construction of an E1-deleted recombinant Ad3CMV-eGFP
-----------------------------------------------------

The recombinant Ad3 bacterial artificial chromosome (BAC) was constructed by ET recombination ([@bib111]) of Ad3 genomic DNA with a BAC-vector carrying subcloned left and right terminal Ad3 fragments ([Fig. 2](#fig2){ref-type="fig"}). We constructed the pBSAd3LRzeo plasmid containing the left and right end of Ad3 genome as follows. Two PCR-generated fragments were cloned into pBluescript (ks+). The first fragment encompassed 468 bp of the Ad3 left end sequence and was PCR-amplified using the forward primer 5′-GATCTCTAGACGCGTCTATCTATATAATATACCTTATAG-3′ (inserting the restriction sites *Xba*I and *Mlu*I) and the reverse primer 5′-GATCGAATTCGGTACCACTAGTATTTAAATTAGCGATCAGCTGACACC-3′ (inserting the restriction sites *Swa*I and *Eco*RI). This first fragment was cloned into pBluescript by *Xba*I and *Eco*RI restriction sites. An additional cloning step was used to introduce an *Avr*II site downstream of the *Eco*RI site of this intermediate product. The second fragment encompassed 528 bp of the Ad3 right end sequence and was PCR-amplified using the forward primer 5′-AGAGCCTAGGAGCAAAGCCACCCCTCGCGG-3′ (adding the restriction site *Avr*II) and the reverse primer 5′-AAAAGGATCCACGCGTCTATCTATATAATATACCTTATAG-3′ (adding the sites *Mlu*I and *Bam*HI). This second fragment was cloned by *Avr*II and *Bam*HI restriction sites. An *Avr*II--*Pvu*II fragment containing the zeocine resistance marker from pcDNA3.1 zeo (Invitrogen) was cloned into the *Avr*II and *Swa*I site, connecting the two Ad3 arms and resulting in pBSAd3LRzeo. In order to transfer the Ad3LRzeo cassette to the BACmid pKSB2, the *Not*I--*Hin*dIII fragment containing this sequence was ligated with the *Not*I--*Hin*dIII-restricted pKSB2 vector. The pKSB2 is a single copy plasmid that supports stable maintenance of large DNA fragments in *E. coli* and a derivative of the BAC vector pKSO ([@bib64]) with a modified polylinker (*Pme*I--*Nsi*I--*Pac*I--*Not*I--*Sfi*I--*Cla*I--*Bam*HI--*Sac*II--*Hin*dIII). Colonies containing pKSB2Ad3LRzeo were selected using chloramphenicol and zeocin™ at concentrations of 10 μg/ml and 25 μg/ml, respectively.

In order to generate pKSB2Ad3wt, which contained the complete Ad3 genome, homologous recombination in DH10B (Invitrogen) was performed. For this, chemically competent DH10B cells were first transformed with the pKD46 plasmid, which encodes the arabinose-inducible phage lambda recombinases *redα* (*exo*), *redβ* (*bet*), and *redγ* (*gam*) ([@bib18]). For recombinase induction, DH10B bacteria were grown at a reduced temperature of 30 °C (which is crucial for maintenance of pKD46) in LB ampicillin (50 μg/ml) and 0.1% (w/v) arabinose. Arabinose-induced electrocompetent cells were co-transformed with *Sal*I-linearized pKSB2Ad3LRzeo and genomic wt Ad3 DNA and were selected on chloramphenicol plates. Nine of ten colonies revealed correct integration in pKSB2Ad3wt, which was verified by *Bam*HI restriction analysis.

In order to insert the eGFP/zeo expression cassette into pKSB2Ad3wt, DH10B bacteria containing the BACmid pKSB2 Ad3wt were re-transformed with pKD46 and re-induced followed by transformation with a PCR-amplified fragment containing an eGFP/zeo cassette. The eGFP/zeo cassette contained the CMV-driven eGFP gene and an EM7-driven zeocin resistance gene derived from pcDNA3.1 zeo (Invitrogen). The expression cassette was flanked by short homologous Ad3 sequences of 40 bp, which were introduced using the PCR forward primer 5′-TGCCAGCGAGAAGAGTTTTCTCCTCCGCGCCGCAAGTCAGTCGGATCTGATCAGCACGTG-3′ and the reverse primer 5′-TTGGTAATCACATTATGTTCAAATACAGGCCATTTTTTGCGAATTCATGTTCTTTCCTGC-3′. The sequence of the forward primer was identical to Ad3 sequence 521 to 560, whereas the second primer was identical to sequence 3030 to 3070, resulting in a 2469-bp deletion of the Ad3 E1 region. This procedure deleted the ORFs encoding E1A and most of E1B but left intact a residual 409-bp stretch of the pIX promoter, similar as described for the Ad35-based vector by [@bib33]. The integrity of the resulting pKSBAd3CMV-eGFP was confirmed by digesting isolated DNAs with restriction enzymes *Bam*HI and *Hin*dIII. Release of the viral genome by the flanking unique *Mlu*I endonuclease sites was followed by transfection of helper 911-Ad3E1B cells. Viral genomic DNAs from rescued virus particles were analyzed using the above restriction enzymes. For large batch preparation of Ad3CMV-eGFP, helper 911-Ad3E1B cells were transiently transfected with the E1B-expression plasmid pcDNA3PGK-Ad3E1B 55 kDa. For this, 2 μg of the pcDNA3PGK-Ad3E1B 55 kDa was calcium-phosphate-precipitated and added to 10^6^ 911-Ad3E1B cells (or multiples thereof with adjusted DNA amounts). The medium was replaced after 8 to 12 h with DMEM 2% HS, and the cells were infected with the recombinant Ad3CMV-eGFP. Virus was amplified using methods described previously ([@bib40]). CsCl purification of Ad3CMV-eGFP yielded 1.6 × 10^8^ fluorescence focus forming units. This rather low yield was likely due to the transient nature of the complementing cells and may be overcome in the future by using a stable cell line expressing higher levels of Ad3 E1B 55-kDa protein.

Establishment of an Ad3 E1B-expressing packaging cell line
----------------------------------------------------------

To allow the generation of E1-deleted Ad3-based vectors, a modified 911 helper cell line ([@bib27]) was produced and characterized, similar as described for other serotype B-based vectors ([@bib33], [@bib43], [@bib101]). For this, 10^6^ 911 cells were transfected with 2 μg of the pcDNA3PGK-Ad3E1B 55-kDa plasmid using calcium phosphate precipitation. Following transfection, G418-resistant 911-Ad3E1B cell clones were established and analyzed by Western blotting for protein expression. The pcDNA3PGK-Ad3E1B 55-kDa plasmid was constructed in two steps. First, the CMV promoter in pcDNA3-turbo-neo ([@bib29]) was removed with *Mfe*I and *Kpn*I and replaced with an *Eco*RI--*Kpn*I fragment of the mouse phosphoglycerate kinase (PGK) promoter, excised from the pPKGneo plasmid. In a second step, the Ad3 E1B 55-kDa sequence was PCR-amplified using the forward primer 5′-AAAGAATTCGGTGGCATGAGGTTCAGAGCG-3′ in combination with the reverse primer 5′-AAATCTAGATTACTTATCGTCGTCATCCTTGTAATCGTCAGTTTCTTCACCACTAGAACC-3′, which introduced a carboxy-terminal Flag-tag. Following digestion with *Eco*RI and *Xba*I, the fragment was cloned in the accordingly restricted pcDNA3PGK vector.

Flow cytometry
--------------

For eGFP expression analysis, triplicates of 1 × 10^5^ cells were infected at multiplicities of infection (MOIs) of 3.3, 10, and 30, washed 2 h post-infection (p.i.) with RPMI 2% HS and analyzed 2 days p.i. by flow cytometric analysis (Cytomics FC500; Beckman Coulter, Fullerton, CA, USA). Mean fluorescence intensities and the overall proportion of infected viable cells were scored.
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[^1]: Cds, coding sequence; ITR, inverted terminal repeat; aa, amino acid residue.

[^2]: Although all three sequences show identical base composition, [AY598970](AY598970) differs by four and [AF532578](AF532578) by eleven nucleotides positions from [AY163756](AY163756).

[^3]: The nucleotide positions of putative motifs are noted in the 5′ to 3′ orientation.

    cds, coding sequence; ITR, inverted terminal repeat; MLP, major late promoter; c, complementary.

[^4]: Splice site predicted using ERPIN RNA structure prediction (see [Materials and methods](#sec1){ref-type="sec"}) cds, coding sequence; ITR, inverted terminal repeat; MLP, major late promoter; c, complementary.

[^5]: C, complementary strand; j, join; hyp, hypothetical.

[^6]: Sizes determined from our sequences may deviate from previously determined values.
